Spero Therapeutics, Inc. (35) | Sales Agreements (1)

Recent Contracts

Controlled Equity Offering Sales Agreement, dated March 11, 2021, by and between the Registrant and Cantor Fitzgerald & Co (Filed With SEC on March 11, 2021)